Literature DB >> 25536604

Overall human papilloma virus and types 16/18 prevalence in women with normal cervical cytology in Serbia: is it time for human papillomavirus testing and/or vaccination?

Emina Malisic1, Ksenija Brotto, Ana Krivokuca, Milena Cavic, Radmila Jankovic.   

Abstract

PURPOSE: Infection with high-risk human papilloma viruses (HR-HPV), especially types 16/18, is the main factor in cervical carcinogenesis. Although the incidence of cervical cancer in Serbia is among the highest ones in Europe, data about HPV infection are insufficient. The aim of this study was to investigate the presence of overall and HPV16/18 infections in women with healthy appearance and cytologically (Pap) normal cervix.
METHODS: The study was performed on women who participated in this cervical cancer screening pilot study. Cervical HPV infection was detected by GP5+/6+ PCR. HPV16/18 were detected by amplification of E7/E1 viral gene, respectively.
RESULTS: In 350 women we got the following results: cytological abnormalities (10.3%); visible cervical changes (20.3%); previous precancerous lesion (2.3%); normal Pap and speculum finding without history of precancerous lesion (67.1%). In the last group overall HPV prevalence was 41.3%, with 10.5% HPV16 and 23.7% HPV18. The rate of multiple HPV16 plus HPV18 infections was 2.6%. HR-HPV16/18 comprised 31.6% of the total HPV positive participants.
CONCLUSION: Owing to the high prevalence of overall and HPV16/18 infections in women with healthy appearance and cytologically normal cervix, we postulate that testing/ prophylaxis for these HR-HPV types could be introduced in cervical cancer screening and preventive programmes in Serbia.

Entities:  

Mesh:

Year:  2014        PMID: 25536604

Source DB:  PubMed          Journal:  J BUON        ISSN: 1107-0625            Impact factor:   2.533


  4 in total

1.  miR-3156-3p is downregulated in HPV-positive cervical cancer and performs as a tumor-suppressive miRNA.

Authors:  Yu-Fang Xia; Gui-Hua Pei; Ning Wang; Yan-Ci Che; Feng-Sheng Yu; Fu-Fen Yin; Hai-Xia Liu; Bing Luo; Yan-Kui Wang
Journal:  Virol J       Date:  2017-02-04       Impact factor: 4.099

2.  Human papilloma and other DNA virus infections of the cervix: A population based comparative study among tribal and general population in India.

Authors:  Supriti Ghosh; Ranjitha S Shetty; Sanjay M Pattanshetty; Sneha D Mallya; Deeksha Pandey; Shama Prasada Kabekkodu; Veena G Kamath; Navya Prabhu; Joslin D'souza; Kapaettu Satyamoorthy
Journal:  PLoS One       Date:  2019-06-27       Impact factor: 3.240

3.  Knowledge about Cervical Cancer and Awareness of Human Papillomavirus (HPV) and HPV Vaccine among Female Students from Serbia.

Authors:  Nataša K Rančić; Milan B Golubović; Mirko V Ilić; Aleksanda S Ignjatović; Radomir M Živadinović; Saša N Đenić; Stefan D Momčilović; Biljana N Kocić; Zoran G Milošević; Suzana A Otašević
Journal:  Medicina (Kaunas)       Date:  2020-08-13       Impact factor: 2.430

4.  The High-Risk Human Papillomavirus E6 Oncogene Exacerbates the Negative Effect of Tryptophan Starvation on the Development of Chlamydia trachomatis.

Authors:  Shardulendra P Sherchand; Joyce A Ibana; Arnold H Zea; Alison J Quayle; Ashok Aiyar
Journal:  PLoS One       Date:  2016-09-22       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.